Generation Bio Co.
GBIO
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Generation Bio Co., společnost zabývající se genetickými léčivými přípravky, vyvíjí terapie pro léčbu vzácných a rozšířených onemocnění. Společnost poskytuje portfolio programů, včetně programů pro vzácné a rozšířené onemocnění jater a retiny. Zaměřuje se také na onemocnění kosterního svalstva, centrálního nervového systému a onkologii. Společnost byla dříve známá jako Torus Therapeutics, Inc. a v listopadu 2017 změnila svůj název na Generation Bio Co. Společnost Generation Bio Co. byla založena v roce 2016 a sídlí v Cambridge ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
115
Založení
2020-06-12
Podobné společnosti
$ 3.66
+ $ 0.18
$ 1.89
+ $ 0.11
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 15.3 | 19.9 | 5.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 1.4 | 0.0 | 79.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 13.9 | 19.9 | -73.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1.6 | 0.8 | 8.7 | 4.2 | 7.6 | 4.1 | 4.1 | 2.9 | 2.1 | 0.9 | |
| Cost of Revenues | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | 1.3 | 1.3 | |
| Gross Profit | 0.2 | 0.8 | 8.7 | 4.2 | 7.6 | 4.1 | 4.1 | 0.9 | 0.9 | -0.4 |
| Operating Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 93.6 | 96.7 | 85.2 | 58.5 | 50.1 | 28.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 50.9 | 44.5 | 33.9 | 22.6 | 12.2 | 9.2 | |
| Depreciation & Amortization | 4.9 | 4.9 | 5.3 | 5.1 | 4.5 | 3.4 | 1.9 | 0.3 | |
| Total Operating Expenses | 98.4 | 162.3 | 144.5 | 141.2 | 119.1 | 81.1 | 62.3 | 37.3 | |
| Operating Income | -84.6 | -142.4 | -138.6 | -141.2 | -119.1 | -81.1 | -62.3 | -37.3 |
| Operating Income | TTM | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 27.9 | 21.9 | 21.8 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.4 | 11.6 | 13.0 | ||
| Depreciation & Amortization | 1.4 | 1.1 | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | ||
| Total Operating Expenses | 21.7 | 23.7 | 25.3 | 27.8 | 25.4 | 27.4 | 81.7 | 41.3 | 33.5 | 34.8 | ||
| Operating Income | -21.5 | -22.9 | -16.6 | -23.6 | -17.9 | -23.3 | -77.6 | -38.4 | -31.4 | -33.9 |
| Net Income | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 7.2 | 10.7 | 12.0 | 4.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 4.5 | 0.1 | 0.6 | 0.0 | 0.0 | |
| Other Expense | 22.0 | 10.7 | 12.0 | 4.5 | -0.1 | 0.6 | 1.0 | 1.5 | |
| IBT | -62.6 | -131.7 | -126.6 | -136.6 | -119.2 | -80.5 | -61.3 | -35.8 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | -4.5 | -4.5 | -4.0 | -1.0 | 1.5 | |
| Net Income | -62.6 | -131.7 | -126.6 | -132.1 | -114.7 | -76.5 | -60.3 | -35.8 |
| Net Income | TTM | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.2 | 2.0 | 1.8 | 2.2 | 2.6 | 2.9 | 3.1 | 3.2 | 3.1 | 2.9 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 16.1 | 0.0 | 0.0 | ||
| Other Expense | 16.0 | 2.0 | 1.8 | 2.2 | 2.6 | 2.9 | 3.1 | 3.2 | 3.1 | 2.9 | ||
| IBT | -5.5 | -20.9 | -14.8 | -21.4 | -15.3 | -20.4 | -74.5 | -35.2 | -28.3 | -31.1 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.4 | -1.3 | 1.2 | ||
| Net Income | -5.5 | -20.9 | -14.8 | -21.4 | -15.3 | -20.4 | -74.5 | -35.2 | -28.3 | -31.1 |
| Per Share Data | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $-19.60 | $-22.70 | $-20.40 | $-28.10 | $-13.10 | $-18.20 | |
| EPS Diluted | $0.00 | $0.00 | $-19.60 | $-22.70 | $-20.40 | $-28.10 | $-13.10 | $-18.20 | |
| Shares Outstanding | 6.7 | 6.7 | 6.4 | 5.8 | 5.6 | 2.7 | 4.6 | 2.0 | |
| Diluted Shares Outstanding | 6.7 | 6.7 | 6.4 | 5.8 | 5.6 | 2.7 | 4.6 | 2.0 |
| Per Share Data | TTM | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-5.30 | $-4.30 | $-4.70 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-5.30 | $-4.30 | $-4.70 | ||
| Shares Outstanding | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.6 | 6.6 | 6.6 | 6.6 | ||
| Diluted Shares Outstanding | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.6 | 6.6 | 6.6 | 6.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 28.5 | 76.3 | 66.4 | 93.2 | 375.1 | 62.9 | 15.1 | 7.3 | |
| Short Term Investments | 188.4 | 108.9 | 197.9 | 185.9 | 0.0 | 199.4 | 0.0 | 67.6 | |
| Total Cash & ST Investments | 216.9 | 185.2 | 264.4 | 279.1 | 375.1 | 262.3 | 15.1 | 74.9 | |
| Accounts Receivable | 1.3 | 1.6 | 4.1 | 0.4 | 0.0 | 0.0 | 0.4 | 1.3 | |
| Inventory | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 5.0 | 6.1 | 4.3 | 7.5 | 4.0 | 5.4 | 0.0 | 0.8 | |
| Total Current Assets | 223.3 | 192.9 | 272.6 | 287.0 | 379.2 | 267.7 | 18.2 | 76.9 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 21.9 | 49.1 | 50.9 | 76.3 | 21.7 | 28.5 | 35.5 | 66.4 | 93.4 | 145.0 | |
| Short Term Investments | 67.7 | 92.3 | 106.7 | 108.9 | 163.1 | 188.4 | 183.8 | 197.9 | 197.7 | 169.2 | |
| Total Cash & ST Investments | 89.6 | 141.4 | 157.6 | 185.2 | 184.8 | 216.9 | 219.3 | 264.4 | 291.0 | 314.1 | |
| Accounts Receivable | 0.0 | 0.3 | 1.4 | 1.6 | 2.2 | 1.3 | 0.0 | 4.0 | 0.7 | 0.3 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.8 | 0.0 | -0.3 | |
| Other Current Assets | 3.8 | 3.9 | 6.2 | 6.1 | 4.3 | 5.0 | 7.5 | 4.1 | 6.1 | 6.1 | |
| Total Current Assets | 93.5 | 145.5 | 165.1 | 192.9 | 191.3 | 223.3 | 226.9 | 272.6 | 297.8 | 320.6 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 39.2 | 35.6 | 95.7 | 81.4 | 91.0 | 23.8 | 21.8 | 4.5 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 2.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.6 | 2.7 | 6.5 | 7.8 | 6.6 | 2.6 | 2.1 | 2.1 | |
| Total Long-Term Assets | 42.0 | 38.3 | 102.1 | 89.2 | 97.6 | 26.4 | 24.0 | 6.6 | |
| Total Assets | 265.3 | 231.2 | 374.8 | 376.3 | 476.8 | 294.2 | 42.1 | 83.5 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 26.3 | 31.7 | 33.8 | 35.6 | 37.2 | 39.2 | 41.6 | 95.7 | 76.8 | 77.8 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 2.2 | 15.0 | 0.0 | 14.6 | 5.8 | 5.7 | 5.7 | |
| Other Long-Term Assets | 2.2 | 2.2 | 2.4 | 0.5 | 5.3 | 2.8 | 2.8 | 0.7 | 1.2 | 0.8 | |
| Total Long-Term Assets | 28.4 | 33.9 | 36.2 | 38.3 | 57.5 | 42.0 | 59.0 | 102.1 | 83.7 | 84.3 | |
| Total Assets | 121.9 | 179.4 | 201.3 | 231.2 | 248.8 | 265.3 | 285.9 | 374.8 | 381.5 | 404.9 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.9 | 1.4 | 2.3 | 0.7 | 2.0 | 0.3 | 2.3 | 1.7 | |
| Short-Term Debt | 8.6 | 13.0 | 18.4 | 7.1 | 4.6 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 5.9 | 10.1 | 16.5 | 11.4 | 0.7 | 11.0 | 6.9 | 4.9 | |
| Current Liabilities | 30.1 | 35.1 | 39.9 | 19.2 | 18.8 | 11.2 | 9.2 | 6.6 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.1 | 2.2 | 2.3 | 1.4 | 1.7 | 1.9 | 1.5 | 2.3 | 2.7 | 2.3 | |
| Short-Term Debt | 6.4 | 9.8 | 9.5 | 13.0 | 10.8 | 8.6 | 8.4 | 8.1 | 17.4 | 16.3 | |
| Other Current Liabilities | 12.5 | 5.9 | 5.8 | 10.1 | 6.2 | 5.9 | 5.7 | 16.5 | 0.8 | -0.4 | |
| Current Liabilities | 21.0 | 19.4 | 19.6 | 35.1 | 30.2 | 30.1 | 28.3 | 39.9 | 32.8 | 26.5 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 85.3 | 80.6 | 89.8 | 74.6 | 76.2 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 85.3 | 93.6 | 97.9 | 81.7 | 80.8 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 149.9 | 145.0 | 171.6 | 93.8 | 95.0 | 26.1 | 140.7 | 125.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 19.7 | 75.6 | 78.1 | 80.6 | 83.0 | 85.3 | 87.6 | 89.8 | 71.0 | 72.5 | |
| Capital Leases | 26.1 | 85.3 | 87.6 | 93.6 | 93.8 | 94.0 | 95.9 | 97.9 | 79.7 | 80.6 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -41.9 | -45.8 | -51.6 | |
| Total Liabilities | 71.3 | 125.3 | 128.0 | 145.0 | 144.3 | 149.9 | 153.9 | 171.6 | 149.6 | 150.6 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -666.4 | -703.0 | -571.4 | -444.8 | -308.1 | -189.0 | -108.5 | -47.1 | |
| Comprehensive Income | -0.3 | 0.2 | 0.3 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 115.4 | 86.2 | 203.1 | 282.5 | 381.7 | 268.0 | -98.6 | -41.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -744.3 | -738.8 | -717.8 | -703.0 | -681.7 | -666.4 | -645.9 | -571.4 | -536.2 | -507.9 | |
| Comprehensive Income | 0.0 | 0.0 | 0.1 | 0.2 | 0.3 | -0.3 | -0.2 | 0.3 | 0.0 | 0.0 | |
| Total Common Equity | 50.6 | 54.1 | 73.3 | 86.2 | 104.4 | 115.4 | 132.0 | 203.1 | 231.9 | 254.3 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 94.0 | 93.6 | 97.9 | 81.7 | 80.8 | 0.0 | 0.0 | 0.0 | |
| Book Value | 115.4 | 86.2 | 203.1 | 282.5 | 381.7 | 268.0 | -98.6 | -41.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 50.6 | 54.1 | 73.3 | 86.2 | 104.4 | 115.4 | 132.0 | 203.1 | 231.9 | 254.3 |
| Cash Flow From Operating Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -158.4 | -131.7 | -126.6 | -136.6 | -119.2 | -80.5 | -61.3 | -35.8 | |
| Depreciation & Amortization | 5.2 | 4.9 | 5.3 | 5.1 | 4.5 | 3.4 | 1.9 | 0.3 | |
| Stock-Based Compensation | 19.7 | 14.6 | 24.3 | 24.5 | 17.9 | 8.4 | 4.2 | 3.5 | |
| Change Working Capital | -18.6 | -31.4 | 53.5 | 1.0 | 4.2 | -1.7 | 15.2 | 4.7 | |
| Change In Accounts Receivable | 44.7 | -1.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -0.3 | -0.4 | 1.1 | -1.4 | 1.8 | -1.4 | 0.8 | 0.2 | |
| Change In Inventories | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 125.9 | 55.0 | -9.3 | 3.6 | 0.8 | 0.2 | -0.3 | -0.8 | |
| Cash from Operations | -103.1 | 0.0 | -52.7 | -102.4 | -91.8 | -70.1 | -40.3 | -28.1 |
| Cash Flow From Operating Activities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -5.5 | -20.9 | -14.8 | -21.4 | -15.3 | -20.4 | -74.5 | -35.2 | -28.3 | -31.1 | |
| Depreciation & Amortization | 1.4 | 1.1 | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | |
| Stock-Based Compensation | 2.0 | 1.7 | 2.0 | 0.0 | 0.0 | 0.0 | 4.0 | 6.0 | 6.0 | 6.0 | |
| Change Working Capital | -26.4 | 1.8 | -16.9 | -0.9 | -7.9 | -5.6 | -17.1 | 5.4 | -1.4 | 50.6 | |
| Change In Accounts Receivable | -0.1 | 1.1 | -0.2 | 1.0 | -0.9 | -1.3 | 0.0 | 46.3 | -0.3 | 1.5 | |
| Change In Accounts Payable | -0.2 | 0.3 | 0.6 | -0.3 | -0.2 | 0.4 | -0.2 | -0.3 | -0.2 | 0.8 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | 0.3 | -1.5 | |
| Other Non-cash Items | -24.1 | -0.5 | 0.1 | 5.3 | 2.5 | 3.2 | 54.6 | 60.3 | -2.5 | -2.1 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -25.0 | -24.9 | 24.8 |
| Cash Flow From Investing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -7.1 | -2.4 | -7.4 | -8.8 | -6.0 | -5.5 | -20.0 | -3.0 | |
| Acquisitions | 21.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -324.9 | -135.3 | -405.3 | -323.7 | 0.0 | -243.2 | -20.8 | -109.9 | |
| Sales of Investment | 315.0 | 232.0 | 403.0 | 140.0 | 198.9 | 43.5 | 88.7 | 43.2 | |
| Other Investing Activities | -19.6 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | |
| Cash from Investing | -17.0 | 0.0 | -9.7 | -192.5 | 193.0 | -205.2 | 48.0 | -69.8 |
| Cash Flow From Investing Activities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | -0.5 | -0.2 | -0.4 | -0.1 | 0.0 | -1.9 | -4.6 | -0.6 | -1.5 | |
| Acquisitions | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | -5.0 | 26.0 | -25.9 | |
| Investments | -14.7 | -9.8 | -41.8 | -19.4 | -29.2 | 0.0 | -86.6 | -109.3 | -129.0 | -79.1 | |
| Sales of Investment | 40.0 | 25.0 | 45.0 | 90.0 | 42.0 | 12.0 | 88.0 | 112.0 | 103.0 | 105.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.0 | -26.0 | 25.9 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.9 | -26.6 | 24.4 |
| Cash Flow From Financing Activities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 13.3 | -4.3 | 16.2 | 0.9 | 80.8 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 1,380.3 | 0.0 | 36.0 | 12.4 | 211.9 | 213.9 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -0.1 | 0.0 | -0.6 | 0.6 | 2.8 | 109.2 | 0.1 | 100.2 | |
| Cash from Financing | 0.1 | 0.0 | 35.8 | 13.0 | 214.7 | 323.1 | 0.1 | 100.2 |
| Cash Flow From Financing Activities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | -59.2 | -2.3 | -6.0 | -0.2 | -0.2 | -2.0 | -1.9 | 18.2 | -0.9 | -1.7 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 1,379.9 | 0.2 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | -0.1 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | -0.1 | 0.1 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | -0.1 | 0.1 |
| Cash position | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -116.4 | 6.2 | -26.6 | -282.0 | 315.9 | 47.8 | 7.7 | 2.3 | |
| Closing Cash Balance | 28.5 | 78.5 | 72.2 | 98.9 | 380.8 | 64.9 | 17.2 | 9.5 |
| Cash position | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -27.2 | -1.8 | -25.4 | 54.6 | -6.8 | -9.2 | -28.7 | -26.8 | -51.6 | 49.3 | |
| Closing Cash Balance | 24.1 | 51.2 | 53.0 | 76.3 | 21.7 | 28.5 | 37.7 | 72.2 | 99.1 | 150.7 |
| Free Cash Flow | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -110.2 | -91.0 | -60.1 | -111.2 | -97.8 | -75.7 | -60.3 | -31.1 | |
| Real Free Cash Flow | -130.0 | -105.6 | -84.5 | -135.7 | -115.6 | -84.1 | -64.5 | -34.6 |
| Free Cash Flow | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -52.7 | -17.3 | -28.6 | -16.2 | -19.6 | -21.5 | -33.6 | -29.6 | -25.5 | 23.4 | |
| Real Free Cash Flow | -54.7 | -19.0 | -30.6 | -16.2 | -19.6 | -21.5 | -37.6 | -35.6 | -31.5 | 17.3 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -0.6 | -4.5 | -1.4 |
| P/S | 2.4 | 18.8 | 9.4 |
| P/B | 0.7 | 1.6 | 5.2 |
| P/FCF | -0.3 | -4.8 | -1.5 |
| Market cap | $0.0 | $5.6 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 21.4 % | 16.6 % | 0 % |
| Debt to Income | -41.7 % | -46.3 % | 0 % |
| Debt to Free cash flow | -21.7 % | -111.9 % | 0 % |
| Interest expense percentage | 0 % | -2.1 % | 44.7 % |
| Current ratio | 4.4 | 14.6 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -123.9 % | -50.3 % | 0 % |
| ROA | -51.4 % | -34.9 % | 0 % |
| CapEx to Revenue | 7.1 % | 32.1 % | 0 % |
| RaD to Revenue | 0 % | 643.4 % | 0 % |
| ROEM | 132,782.6 | 16121.3 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 90.8 % | 10.7 % | 68.7 % |
| Operating margin | -553.9 % | -1057.8 % | 35.5 % |
| Net margin | -410.1 % | -931.5 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 6.7 mil | 5.3 mil |
| Employee count | 0.1 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
